₹ 123.70
1.41 (1.15%)Open
123.99High
127.15Low
123.5Prev Close
122.29P/E
36.42Median P/E
30.61P/B
2.98Median P/B
4.51Market Cap
6.03BPEG
-0.5Div.Yield
-Bid
123.85Ask
124.50Large Cap
6.03B Mkt. Cap.Volatility
-Beta
-99999.99Genie Says
Influencer Count
-Days | BSE | NSE |
---|
5 | 114.76 | 115.03 |
10 | 105.01 | 105.16 |
20 | 101.35 | 101.41 |
50 | 103.72 | 103.77 |
100 | 108.30 | 108.31 |
300 | 114.39 | 114.38 |
BSE
541400NSE
ZIMLABISIN
INE518E01015ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Anwar Daud
Executive Chairman of the Board, Managing DirectorShyam Patro
Chief Financial OfficerZulfiquar Kamal
Director - Finance, Executive DirectorPiyush Nikhade
Compliance Officer, Company SecretaryNiraj Dhadiwal
Director - Business DevelopmentPrakash Sapkal
Director - Operations